• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER II ADDITIONAL SIZES; OCCLUDER, PATENT DUCTUS, ARTERIOSUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER II ADDITIONAL SIZES; OCCLUDER, PATENT DUCTUS, ARTERIOSUS Back to Search Results
Model Number 9-PDA2AS-04-02-L
Device Problems Off-Label Use (1494); Improper or Incorrect Procedure or Method (2017); Obstruction of Flow (2423)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, a patient required coarctation repair after device implant due to an aortic arch obstruction caused by protrusion of the device.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.Please note, per the instructions for use, 600419-004 revision a "the amplatzer duct occluder ii additional sizes is contraindicated for patients who weigh less than 6 kgs.".
 
Event Description
It was reported through a research article identifying amplatzer ado ii that may be related to a complications post procedure.Details are listed in the article, titled "improved ventilation in premature babies after transcatheter versus surgical closure of patent ductus arteriosus." it was reported in the article that one 1000 grams patient implanted with a 4/2mm amplatzer duct occluder ii requiring re-intervention had aortic arch obstruction due to protrusion of the device.The patient made good clinical progress following the procedure.However serial echocardiograms showed increasing aortic arch obstruction.He underwent successful coarctation repair 118 days following initial catheter intervention.This was performed via a posterolateral thoracotomy, with end-to-end anastomosis and with removal of the aortic disc of the device.
 
Manufacturer Narrative
Correction information for d2.Additional information for g4, g7, h2, h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER DUCT OCCLUDER II ADDITIONAL SIZES
Type of Device
OCCLUDER, PATENT DUCTUS, ARTERIOSUS
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key9981673
MDR Text Key188406974
Report Number2135147-2020-00165
Device Sequence Number1
Product Code MAE
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Remedial Action Modification/Adjustment
Type of Report Initial,Followup
Report Date 12/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/21/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-PDA2AS-04-02-L
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Weight1
-
-